{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:01:10Z","timestamp":1791860470114,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":1430,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1124\/dmd.120.000254","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T05:40:22Z","timestamp":1606369222000},"page":"133-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics"],"prefix":"10.1016","volume":"49","author":[{"given":"Mary Alexandra","family":"Schleiff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah R.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasin","family":"Payakachat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin Mark","family":"Schleiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna O.","family":"Pinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Province","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Joshua","family":"Swamidass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Boysen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4743-8187","authenticated-orcid":false,"given":"Grover P.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.120.000254_bib1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11306-014-0676-4","article-title":"Competitive Fragmentation Modeling of ESI-MS\/MS spectra for putative metabolite identification","volume":"11","author":"Allen","year":"2015","journal-title":"Metabolomics"},{"key":"10.1124\/dmd.120.000254_bib2","doi-asserted-by":"crossref","first-page":"W94","DOI":"10.1093\/nar\/gku436","article-title":"CFM-ID: a web server for annotation, spectrum prediction and metabolite identification from tandem mass spectra","volume":"42","author":"Allen","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/dmd.120.000254_bib3","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1021\/acs.chemrestox.8b00005","article-title":"Cytochromes P450 1A2 and 3A4 catalyze the metabolic activation of sunitinib","volume":"31","author":"Amaya","year":"2018","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.120.000254_bib4","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3390\/ijms17050632","article-title":"Advantages and pitfalls of mass spectrometry based metabolome profiling in systems biology","volume":"17","author":"Aretz","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1124\/dmd.120.000254_bib5","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1021\/tx0501637","article-title":"Cyanide trapping of iminium ion reactive intermediates followed by detection and structure identification using liquid chromatography-tandem mass spectrometry (LC-MS\/MS)","volume":"18","author":"Argoti","year":"2005","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.120.000254_bib6","series-title":"Meyler\u2019s Side Effects of Drugs","first-page":"361","article-title":"Flufenamic acid and meclofenamic acid","author":"Aronson","year":"2016"},{"key":"10.1124\/dmd.120.000254_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bcp.2018.07.043","article-title":"Lamisil (terbinafine) toxicity: determining pathways to bioactivation through computational and experimental approaches","volume":"156","author":"Barnette","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.120.000254_bib8","doi-asserted-by":"crossref","first-page":"113661","DOI":"10.1016\/j.bcp.2019.113661","article-title":"Comprehensive kinetic and modeling analyses revealed CYP2C9 and 3A4 determine terbinafine metabolic clearance and bioactivation","volume":"170","author":"Barnette","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.120.000254_bib9","doi-asserted-by":"crossref","first-page":"152478","DOI":"10.1016\/j.tox.2020.152478","article-title":"Dual mechanisms suppress meloxicam bioactivation relative to sudoxicam","volume":"440","author":"Barnette","year":"2020","journal-title":"Toxicology"},{"key":"10.1124\/dmd.120.000254_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1021\/acs.chemrestox.6b00256","article-title":"formation and biological targets of quinones: cytotoxic versus cytoprotective effects","volume":"30","author":"Bolton","year":"2017","journal-title":"Chem Res Toxicol"},{"issue":"Suppl 1","key":"10.1124\/dmd.120.000254_bib11","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1097\/00002508-199108000-00007","article-title":"Pharmacology, pharmacokinetics, and therapeutic use of meclofenamate sodium","volume":"7","author":"Conroy","year":"1991","journal-title":"Clin J Pain"},{"key":"10.1124\/dmd.120.000254_bib12","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1124\/dmd.111.040865","article-title":"Small molecule quantification by liquid chromatography-mass spectrometry for metabolites of drugs and drug candidates","volume":"39","author":"Dahal","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.000254_bib13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3399\/bjgp16X684433","article-title":"The dangers of NSAIDs: look both ways","volume":"66","author":"Davis","year":"2016","journal-title":"Br J Gen Pract"},{"key":"10.1124\/dmd.120.000254_bib14","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1021\/acs.chemrestox.9b00006","article-title":"CYP2C19 and 3A4 dominate metabolic clearance and bioactivation of terbinafine based on computational and experimental approaches","volume":"32","author":"Davis","year":"2019","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.120.000254_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pharmthera.2009.05.011","article-title":"Cooperative properties of cytochromes P450","volume":"124","author":"Denisov","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.120.000254_bib16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/metabo9040072","article-title":"CFM-ID 3.0: significantly improved ESI-MS\/MS prediction and compound identification","volume":"9","author":"Djoumbou-Feunang","year":"2019","journal-title":"Metabolites"},{"key":"10.1124\/dmd.120.000254_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/tx034170b","article-title":"Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development","volume":"17","author":"Evans","year":"2004","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.120.000254_bib18","first-page":"891","article-title":"Bioactivation of tamoxifen to metabolite E quinone methide: reaction with glutathione and DNA","volume":"29","author":"Fan","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.000254_bib19","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1021\/acs.jcim.0c00361","article-title":"XenoNet: inference and likelihood of intermediate metabolite formation","volume":"60","author":"Flynn","year":"2020","journal-title":"J Chem Inf Model"},{"key":"10.1124\/dmd.120.000254_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0009-2797(02)00052-2","article-title":"Idiosyncratic NSAID drug induced oxidative stress","volume":"142","author":"Galati","year":"2002","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.120.000254_bib21","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1021\/tx0496791","article-title":"Dansyl glutathione as a trapping agent for the quantitative estimation and identification of reactive metabolites","volume":"18","author":"Gan","year":"2005","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.120.000254_bib22","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1021\/tx800368n","article-title":"In vitro screening of 50 highly prescribed drugs for thiol adduct formation--comparison of potential for drug-induced toxicity and extent of adduct formation","volume":"22","author":"Gan","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.120.000254_bib23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/pds.1207","article-title":"A systematic review of NSAIDs withdrawn from the market due to hepatotoxicity: lessons learned from the bromfenac experience","volume":"15","author":"Goldkind","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1124\/dmd.120.000254_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.arabjc.2010.12.006","article-title":"Spectrophotometric and spectrofluorometric methods for the determination of non-steroidal anti-inflammatory drugs: a review","volume":"6","author":"Gouda","year":"2013","journal-title":"Arab J Chem"},{"key":"10.1124\/dmd.120.000254_bib25","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1124\/dmd.117.075259","article-title":"Implications for metabolite quantification by mass spectrometry in the absence of authentic standards","volume":"45","author":"Hatsis","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.000254_bib26","first-page":"HS5","article-title":"Adverse events associated with NSAIDs","volume":"33","author":"Hawboldt","year":"2008","journal-title":"US Pharm"},{"key":"10.1124\/dmd.120.000254_bib27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1021\/acscentsci.6b00162","article-title":"Modeling reactivity to biological macromolecules with a deep multitask network","volume":"2","author":"Hughes","year":"2016","journal-title":"ACS Cent Sci"},{"key":"10.1124\/dmd.120.000254_bib28","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/acs.chemrestox.5b00017","article-title":"Site of reactivity models predict molecular reactivity of diverse chemicals with glutathione","volume":"28","author":"Hughes","year":"2015","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.120.000254_bib29","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1021\/acs.chemrestox.6b00385","article-title":"Deep learning to predict the formation of quinone species in drug metabolism","volume":"30","author":"Hughes","year":"2017","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.120.000254_bib30","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1248\/yakushi.13-00144","article-title":"Enhancement of quinone hepatotoxicity by cytochrome P450 inhibition","volume":"133","author":"Ishihara","year":"2013","journal-title":"Yakugaku Zasshi"},{"key":"10.1124\/dmd.120.000254_bib31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/jat.1578","article-title":"Crucial role of cytochrome P450 in hepatotoxicity induced by 2,3-dimethoxy-1,4-naphthoquinone in rats","volume":"31","author":"Ishihara","year":"2011","journal-title":"J Appl Toxicol"},{"key":"10.1124\/dmd.120.000254_bib32","series-title":"Quinone-Induced Hepatotoxicity, in Hepatotoxicity","first-page":"450","article-title":"A role of cytochrome","author":"Ishihara","year":"2008"},{"key":"10.1124\/dmd.120.000254_bib33","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1021\/tx8002356","article-title":"Bioactivation of lumiracoxib by peroxidases and human liver microsomes: identification of multiple quinone imine intermediates and GSH adducts","volume":"22","author":"Kang","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.120.000254_bib34","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1124\/dmd.106.010249","article-title":"Enzyme source effects on CYP2C9 kinetics and inhibition","volume":"34","author":"Kumar","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.000254_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.toxlet.2009.01.005","article-title":"The relationship between diphenylamine structure and NSAIDs-induced hepatocytes injury","volume":"186","author":"Li","year":"2009","journal-title":"Toxicol Lett"},{"key":"10.1124\/dmd.120.000254_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cbi.2008.09.014","article-title":"Recent advances in applications of liquid chromatography-tandem mass spectrometry to the analysis of reactive drug metabolites","volume":"179","author":"Ma","year":"2009","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.120.000254_bib37","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0006-2952(99)00163-X","article-title":"Diphenylamine as an important structure of nonsteroidal anti-inflammatory drugs to uncouple mitochondrial oxidative phosphorylation","volume":"58","author":"Masubuchi","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.120.000254_bib38","first-page":"627","article-title":"On the mechanism of the pharmacologic activity of meclofenamate sodium","volume":"33","author":"McLean","year":"1983","journal-title":"Arzneimittelforschung"},{"key":"10.1124\/dmd.120.000254_bib39","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bmcl.2005.07.067","article-title":"QSAR analysis of meclofenamic acid analogues as selective COX-2 inhibitors","volume":"16","author":"Narsinghani","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/dmd.120.000254_bib40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0378-5173(95)04343-8","article-title":"Bioavailability of meclofenamate from experimental sustained-release microcapsules in beagle dogs","volume":"134","author":"Niazy","year":"1996","journal-title":"Int J Pharm"},{"key":"10.1124\/dmd.120.000254_bib41","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1440-1746.2011.07036.x","article-title":"Severe acute liver injury associated with lumiracoxib","volume":"27","author":"Pillans","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1124\/dmd.120.000254_bib42","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.3390\/molecules25204820","article-title":"Significance of competing metabolic pathways for 5F-APINACA based on quantitative kinetics","volume":"25","author":"Pinson","year":"2020","journal-title":"Molecules"},{"key":"10.1124\/dmd.120.000254_bib43","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/0006-2952(71)90267-X","article-title":"Effects of non-steroid antirheumatic agents on microsomal drug-metabolizing enzymes of rat liver","volume":"20","author":"Reinicke","year":"1971","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.120.000254_bib44","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1002\/jssc.201000465","article-title":"Study of atypical kinetic behaviour of cytochrome P450 2C9 isoform with diclofenac at low substrate concentrations by sweeping-MEKC combination","volume":"33","author":"\u0158em\u00ednek","year":"2010","journal-title":"J Sep Sci"},{"key":"10.1124\/dmd.120.000254_bib45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11306-009-0168-0","article-title":"Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research","volume":"5","author":"Scalbert","year":"2009","journal-title":"Metabolomics"},{"key":"10.1124\/dmd.120.000254_bib46","first-page":"544","article-title":"Solubility of buffers in aqueous\u2013organic eluents for reversed-phase liquid chromatography","volume":"22","author":"Schellinger","year":"2004","journal-title":"LC GC N Am"},{"key":"10.1124\/dmd.120.000254_bib47","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/03602532.2020.1765793","article-title":"Advances in the study of drug metabolism \u2013 symposium report of the 12th Meeting of the International Society for the Study of Xenobiotics (ISSX)","volume":"52","author":"Schleiff","year":"2020","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.120.000254_bib48","first-page":"530","article-title":"Liver injury induced by the non-steroidal anti-inflammatory drug mefenamic acid","volume":"45","author":"Somchit","year":"2004","journal-title":"Singapore Med J"},{"key":"10.1124\/dmd.120.000254_bib49","first-page":"5253623","article-title":"Hepatotoxicity of nonsteroidal anti-inflammatory drugs: a systematic review of randomized controlled trials","volume":"2018","author":"Sriuttha","year":"2018","journal-title":"Int J Heptol"},{"key":"10.1124\/dmd.120.000254_bib50","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/med.21273","article-title":"The generation, detection, and effects of reactive drug metabolites","volume":"33","author":"Stachulski","year":"2013","journal-title":"Med Res Rev"},{"key":"10.1124\/dmd.120.000254_bib51","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/acs.chemrestox.5b00410","article-title":"Reactive metabolites: current and emerging risk and hazard assessments","volume":"29","author":"Thompson","year":"2016","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.120.000254_bib52","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","article-title":"Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs","volume":"340","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.120.000254_bib53","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/00498250410001691271","article-title":"Influence of different recombinant systems on the cooperativity exhibited by cytochrome P4503A4","volume":"34","author":"Zhang","year":"2004","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.120.000254_bib54","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1570-0232(03)00399-4","article-title":"Separation and detection methods for covalent drug-protein adducts","volume":"797","author":"Zhou","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624080668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624080668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.120.000254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T12:53:23Z","timestamp":1740056003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624080668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0090955624080668"],"URL":"https:\/\/doi.org\/10.1124\/dmd.120.000254","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.120.000254","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s)","name":"copyright","label":"Copyright"}]}}